TickerFacts.

Endovia Health Sciences, Inc. (EDVA): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2020-12-31, 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.80M
Year ended 2024-12-31
-19.9%
3-year compound annual growth
$13.28M2011-12-31: $145.8K2012-12-31: $131.0K2013-12-31: $236.3K2014-12-31: $256.1K2015-12-31: $427.0K2016-12-31: $484.9K2017-12-31: $440.4K2018-12-31: $605.3K2019-12-31: $245.5K2020-12-31: $1.94M2021-12-31: $7.40M2022-12-31: $12.17M2023-12-31: $13.28M2024-12-31: $3.80M$3.80M
2011-12-31 Cost of Revenue (USD) 2024-12-31
Period endedCost of RevenueChange YoYSource filing
2024-12-31$3.80M-71.4%2025-07-11, From 2024-01-01
2023-12-31$13.28M+9.1%2025-07-11, From 2023-01-01
2022-12-31$12.17M+64.5%2024-03-29, From 2022-01-01
2021-12-31$7.40Mn/c2023-03-31, From 2021-01-01
2020-12-31$1.94Mn/c2022-03-31, From 2020-01-01
2019-12-31$245.5K-59.4%2021-03-08, From 2019-01-01
2018-12-31$605.3K+37.4%2020-03-27, From 2018-01-01
2017-12-31$440.4K-9.2%2019-03-29, From 2017-01-01
2016-12-31$484.9K+13.6%2018-04-02, From 2016-01-01
2015-12-31$427.0K+66.7%2017-03-28, From 2015-01-01
2014-12-31$256.1K+8.4%2016-10-03, From 2014-01-01
2013-12-31$236.3K+80.3%2016-09-21, From 2013-01-01
2012-12-31$131.0K-10.2%2014-04-18, From 2012-01-01
2011-12-31$145.8Kn/a2013-04-24, From 2011-01-01